|
US7199231B1
(en)
|
1991-05-23 |
2007-04-03 |
Ludwig Institute For Cancer Research |
Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-4 and 41 and uses thereof
|
|
GB9524973D0
(en)
|
1995-12-06 |
1996-02-07 |
Lynxvale Ltd |
Viral vectors
|
|
WO2000020445A2
(en)
|
1998-10-02 |
2000-04-13 |
Ludwig Institute For Cancer Research |
Tumor antigens and ctl clones isolated by a novel procedure
|
|
US7311914B2
(en)
|
2002-08-13 |
2007-12-25 |
Ludwig Institute For Cancer Research |
MAGE-A4 antigenic peptides and uses thereof
|
|
AU2003264009A1
(en)
|
2002-08-15 |
2004-03-03 |
Epitomics, Inc. |
Humanized rabbit antibodies
|
|
EP1651659A4
(en)
|
2003-08-07 |
2008-09-17 |
Epitomics Inc |
METHOD FOR HUMANIZATION OF MONOCLONAL RABBIT ANTIBODIES
|
|
US7807392B1
(en)
|
2003-09-15 |
2010-10-05 |
Celera Corporation |
Lung disease targets and uses thereof
|
|
CN101287831B
(zh)
|
2005-09-13 |
2013-05-15 |
国立大学法人三重大学 |
T细胞受体和编码该受体的核酸
|
|
IN2009DN05758A
(https=)
|
2007-03-12 |
2015-07-24 |
Esbatech Ag |
|
|
KR20170036814A
(ko)
|
2007-05-21 |
2017-04-03 |
앨더바이오 홀딩스 엘엘씨 |
신규한 래빗 항체 인간화 방법 및 인간화된 래빗 항체
|
|
US20090074780A1
(en)
|
2007-06-25 |
2009-03-19 |
David Urech |
Methods of modifying antibodies, and modified antibodies with improved functional properties
|
|
KR101530723B1
(ko)
|
2007-06-25 |
2015-06-22 |
에스바테크 - 어 노바티스 컴파니 엘엘씨 |
단일 쇄 항체의 서열에 기초한 공학처리 및 최적화
|
|
PL3241843T3
(pl)
|
2008-06-25 |
2021-12-27 |
Novartis Ag |
Optymalizacja rozpuszczalności cząsteczek immunowiążących
|
|
CN104004094B
(zh)
|
2008-06-25 |
2017-09-22 |
艾斯巴技术-诺华有限责任公司 |
使用通用抗体构架进行的兔抗体的人源化
|
|
WO2011025964A2
(en)
*
|
2009-08-29 |
2011-03-03 |
Abbott Laboratories |
Therapeutic dll4 binding proteins
|
|
EP2760892A1
(en)
|
2011-09-29 |
2014-08-06 |
Apo-T B.V. |
Multi-specific binding molecules targeting aberrant cells
|
|
BR112017011166A2
(pt)
|
2014-11-26 |
2018-02-27 |
Xencor, Inc. |
anticorpos heterodiméricos que se ligam a cd3 e cd38
|
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
|
PL3440105T3
(pl)
|
2016-04-08 |
2022-08-29 |
Immunocore Limited |
Receptory komórek t
|
|
SMT202100564T1
(it)
|
2016-04-08 |
2022-01-10 |
Adaptimmune Ltd |
Recettori di cellule t
|
|
CA3020555A1
(en)
|
2016-04-08 |
2017-10-12 |
Adaptimmune Limited |
T cell receptors
|
|
CN116987189A
(zh)
|
2016-05-20 |
2023-11-03 |
哈普恩治疗公司 |
单链可变片段cd3结合蛋白质
|
|
US11590098B2
(en)
*
|
2016-09-06 |
2023-02-28 |
Mayo Foundation For Medical Education And Research |
Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins
|
|
KR20190142767A
(ko)
|
2017-03-20 |
2019-12-27 |
제노세아 바이오사이언스, 인코퍼레이티드 |
치료 방법
|
|
US11497768B2
(en)
|
2017-06-05 |
2022-11-15 |
Mie University |
Antigen-binding protein that recognizes MAGE-A4-derived peptide
|
|
AU2018318303A1
(en)
|
2017-08-18 |
2020-04-09 |
Gritstone Bio, Inc. |
Antigen-binding proteins targeting shared antigens
|
|
US20210061914A1
(en)
|
2017-12-28 |
2021-03-04 |
Gritstone Oncology, Inc. |
Antigen-Binding Proteins Targeting Shared Antigens
|
|
GB201803750D0
(en)
|
2018-03-08 |
2018-04-25 |
Immunocore Ltd |
Method
|
|
JP7326764B2
(ja)
|
2018-03-09 |
2023-08-16 |
東ソー株式会社 |
腫瘍マーカーならびに腫瘍細胞を夾雑細胞と区別して回収および検出する方法
|
|
AU2019283639A1
(en)
|
2018-06-04 |
2021-01-07 |
Apo-T B.V. |
Methods and means for attracting immune effector cells to tumor cells
|
|
CN108866098A
(zh)
|
2018-07-27 |
2018-11-23 |
北京安斯晨睿生物科技有限公司 |
携带mage-a4突变抗原基因的重组腺相关病毒载体及其构建方法与应用
|
|
GB201819540D0
(en)
|
2018-11-30 |
2019-01-16 |
Adaptimmune Ltd |
T cell modification
|
|
GB201901306D0
(en)
|
2019-01-30 |
2019-03-20 |
Immunocore Ltd |
Multi-domain binding molecules
|
|
EP3714941A1
(en)
|
2019-03-27 |
2020-09-30 |
Medigene Immunotherapies GmbH |
Mage-a4 tcrs
|
|
BR112021025548A2
(pt)
|
2019-06-18 |
2022-05-17 |
Regeneron Pharma |
Receptores de células t mage-a4 e métodos de uso dos mesmos
|
|
MX2022000896A
(es)
*
|
2019-07-24 |
2022-02-14 |
Regeneron Pharma |
Receptores de antigenos quimericos con especificidad por mage-a4 y usos de los mismos.
|
|
DE102019121007A1
(de)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
|
CN110333352A
(zh)
|
2019-08-07 |
2019-10-15 |
基因科技（上海）股份有限公司 |
肿瘤相关自身抗体及肿瘤标志物联合检测试剂盒
|
|
CR20220256A
(es)
|
2019-12-18 |
2022-08-31 |
Hoffmann La Roche |
Anticuerpos que se unen a hla-a2/mage-a4
|
|
CN115803340A
(zh)
|
2020-04-24 |
2023-03-14 |
纪念斯隆凯特琳癌症中心 |
抗cd3抗体及其用途
|
|
CN116096754A
(zh)
|
2020-05-04 |
2023-05-09 |
免疫里森公司 |
前体三特异性抗体构建体及其使用方法
|
|
JP2023526259A
(ja)
|
2020-05-13 |
2023-06-21 |
アダプティミューン・リミテッド |
がんまたは腫瘍の治療の方法
|
|
US20230190803A1
(en)
|
2020-05-13 |
2023-06-22 |
Adaptimmune Limited |
Method of treatment of cancer or tumour
|
|
CN114524878B
(zh)
|
2020-11-23 |
2024-08-02 |
康诺亚生物医药科技（成都）有限公司 |
一种双特异性抗体及其用途
|
|
US11912771B2
(en)
|
2021-03-09 |
2024-02-27 |
Cdr-Life Ag |
MAGE-A4 peptide-MHC antigen binding proteins
|
|
EP4304725A1
(en)
|
2021-03-09 |
2024-01-17 |
CDR-Life AG |
Rabbit-derived antigen binding protein nucleic acid libraries
|
|
CA3217914A1
(en)
|
2021-05-04 |
2022-11-10 |
Kevin BRAY |
Chimeric antigen receptors with mage-a4 specificity and uses thereof
|
|
US20240218065A1
(en)
|
2021-06-15 |
2024-07-04 |
Shenghe (China) Biopharmaceutical Co. |
Multispecific antigen-binding protein and use thereof
|
|
US20240336682A1
(en)
|
2021-08-02 |
2024-10-10 |
Shenghe (China) Biopharmaceutical Co., Ltd. |
Multispecific antigen-binding protein and use thereof
|
|
US20240327543A1
(en)
|
2021-08-02 |
2024-10-03 |
Shenghe (China) Biopharmaceutical Co., Ltd. |
Multispecific antigen-binding protein and use thereof
|
|
CN118043357A
(zh)
|
2021-08-04 |
2024-05-14 |
阿布普罗公司 |
Cd3靶向抗体及其用途
|
|
IL311039A
(en)
|
2021-09-17 |
2024-04-01 |
Adimab Llc |
Anti-cd3 antibodies
|